Industry News

Altasciences companies receive CRO Leadership Awards

Centerwatch - Thu, 2015-02-19 08:08
Altasciences has announced that its companies, Algorithme Pharma (Montreal, Canada) and Vince & Associates Clinical Research (Kansas), are both 2015 CRO Leadership Award recipients.
Categories: Industry News

FDA grants Genentech’s cobimetinib Priority Review for melanoma

Centerwatch - Thu, 2015-02-19 08:00
The FDA has accepted and granted Priority Review for Genentech’s, a member of the Roche Group, NDA for cobimetinib in combination with Zelboraf (vemurafenib) for the treatment of people with BRAF V600 mutation-positive advanced melanoma. The FDA will make a decision on approval by Aug. 11.
Categories: Industry News

NIH trial compares three drugs for diabetic macular edema

Centerwatch - Thu, 2015-02-19 07:49
In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial. However, the three drugs resulted in similar average improvement when starting vision was 20/40 to 20/32. Investigators found no major differences in the safety of the three drugs. The trial was funded by the National Eye Institute (NEI), part of the NIH.
Categories: Industry News

Safe Use Initiative

FDA News - Wed, 2015-02-18 13:05
Updated
Categories: Industry News

Theorem Clinical Research, Biomedical Systems partner

Centerwatch - Wed, 2015-02-18 06:58
Theorem Clinical Research, a global CRO based in King of Prussia, Pa., and Biomedical Systems, a provider of comprehensive centralized diagnostic services, have formed a strategic partnership to expand a suite of services available to clients worldwide.
Categories: Industry News

Actavis to divest Pharmatech to TPG

Centerwatch - Wed, 2015-02-18 06:57
Actavis, headquartered in Dublin, and TPG, a global private investment firm, have entered into definitive agreements under which Actavis will divest to TPG the business currently known as Aptalis Pharmaceutical Technologies (Pharmatech)—a pharmaceutical outsourcing and R&D business operating in the U.S., Canada and Europe (where the transaction is, in certain jurisdictions, still subject to local regulations, discussions and clearances). No other Aptalis businesses or products are included in the transaction. Financial terms have not been disclosed. 
Categories: Industry News

Alzheimer's Research U.K. launches three Drug Discovery Institutes

Centerwatch - Wed, 2015-02-18 06:57
Alzheimer's Research U.K., a dedicated dementia research charity, has announced a $46.3 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and University College London (UCL). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer's disease and other dementias.
Categories: Industry News

CRF Health, Vodafone partner

Centerwatch - Wed, 2015-02-18 06:56
CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry based in Plymouth Meeting, Pa., has announced a new partnership with Vodafone, a British multinational telecommunications company. CRF Health will use Vodafone’s global Machine-to-Machine (M2M) platform to offer an enhanced service to clinical trial operators and their patients.
Categories: Industry News

Sanofi, Lead Pharma partner to develop treatments for autoimmune diseases

Centerwatch - Wed, 2015-02-18 06:55
Sanofi has entered into a research collaboration and license agreement with Dutch biotech Lead Pharma to discover, develop and commercialize small-molecule therapies directed against the nuclear hormone receptors called ROR gamma t to treat a broad range of autoimmune disorders, including rheumatoid arthritis, psoriasis and inflammatory bowel disease, which are among the most common.
Categories: Industry News

Certara to launch version 8.0 of D360 big data platform

Centerwatch - Wed, 2015-02-18 06:54
Certara, a global biosimulation technology-enabled drug development and drug safety consulting company, will be launching version 8.0 of its D360 R&D big data platform for the biopharmaceutical industry.
Categories: Industry News

Parexel continues to expand Site Alliance Network

Centerwatch - Wed, 2015-02-18 06:51
Parexel International, a global biopharmaceutical services provider, has announced the continued expansion of its clinical trial Site Alliance Network, an extensive network of investigator sites and site management organizations (SMOs) that enables Parexel to quickly access and enroll patient populations for clients' clinical trials worldwide.
Categories: Industry News

Angle, MD Anderson Cancer Center collaborate on colorectal cancer

Centerwatch - Wed, 2015-02-18 06:49
Angle, a specialist medtech company based in England, is collaborating with the MD Anderson Cancer Center to investigate the clinical use of Angle's Parsortix system as a companion diagnostic in colorectal cancer. The University of Texas MD Anderson Cancer Center is a center devoted exclusively to cancer patient care, research, education and prevention.
Categories: Industry News

Siro Clinpharm relocates corporate offices

Centerwatch - Wed, 2015-02-18 06:48
SIRO Clinpharm, an India-based CRO, has relocated its corporate headquarters within Mumbai, India. The move allows SIRO to consolidate its position in the Indian healthcare development space.
Categories: Industry News

Dako, Ono Pharmaceutical to collaborate on diagnostic test Opdivo

Centerwatch - Wed, 2015-02-18 06:45
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Ono Pharmaceutical, headquartered in Osaka, Japan, have partnered to develop a potential diagnostic test specifically for use with Opdivo in the treatment of non-small cell lung cancer. This test is being investigated for its diagnostic utility to determine which patients are most likely to respond to Opdivo.
Categories: Industry News

Additions/Deletions for Prescription and OTC Drug Product Lists

FDA News - Tue, 2015-02-17 11:43
The list has been updated through January 2015.
Categories: Industry News

Clinical trials consultant, author Karen Woodin will be missed

Centerwatch - Tue, 2015-02-17 05:23
Karen Estelle Woodin, Ph.D., known in the clinical trials industry as a long-time industry consultant and author, passed away last week after a short bout with malignant endometrial cancer.  She was 74.
Categories: Industry News

The Keys to success in Site Selection

Centerwatch - Tue, 2015-02-17 03:00
The keys to successful study conduct at the site level are honesty, integrity and transparency:
Categories: Industry News

A Method for Enhancing Sleep in PTSD

sleep - Mon, 2015-02-16 19:00
Status: Not yet recruiting, Condition Summary: PTSD; Sleep Problems
Categories: Industry News

Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance

sleep - Mon, 2015-02-16 19:00
Status: Completed, Condition Summary: Post-traumatic Stress Disorder
Categories: Industry News

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

sleep - Sun, 2015-02-15 19:00
Status: Recruiting, Condition Summary: Sleep Disorders
Categories: Industry News
Syndicate content